600 Federal Register / Vol. 71, No. 3 / Thursday, January 5, 2006 / Notices 

Peter J. King, 

Deputy Director, Bureau of Certification and 

Licensing. 

[FR Doc. E5–8321 Filed 1–4–06; 8:45 am] 

BILLING CODE 6730–01–P 

FEDERAL MARITIME COMMISSION 

Ocean Transportation Intermediary 

License Revocations 

The Federal Maritime Commission 

hereby gives notice that the following 

Ocean Transportation Intermediary 

licenses have been revoked pursuant to 

section 19 of the Shipping Act of 1984 

(46 U.S.C. app. 1718) and the 

regulations of the Commission 

pertaining to the licensing of Ocean 

Transportation Intermediaries, effective 

on the corresponding date shown below: 

License Number: 004059F. 

Name: Pacific Multi-Modal, Inc. 

Address: 840 West 12th Street, Long 

Beach, CA 90813. 

Date Revoked: November 30, 2005. 

Reason: Failed to maintain a valid bond. 

License Number: 018249F. 

Name: JJB Trucking Services Corp. & 

Shipping. 

Address: 333 N. Broad Street, Elizabeth, 

NJ 07200. 

Date Revoked: December 2, 2005. 

Reason: Failed to maintain a valid bond. 

License Number: 003722F. 

Name: Falcon Transportation & 

Forwarding Corp. 

Address: 500 Bi-County Boulevard, 

Suite 213N, Farmingdale, NY 11735. 

Date Revoked: November 20, 2005. 

Reason: Failed to maintain a valid bond. 

License Number: 018793NF. 

Name: Berr International, Inc. 

Address: 8344 NW 30 Terrace, Miami, 

FL 33122. 

Date Revoked: December 17, 2005. 

Reason: Failed to maintain a valid bond. 

License Number: 001227F. 

Name: Fast Shipping Co. 

Address: P.O. Box 523363, Miami, FL 

33152. 

Date Revoked: November 23, 2005. 

Reason: Surrendered license 

voluntarily. 

License Number: 015593NF. 

Name: Cross Trans Service USA, Inc. 

Address: 1480 Elmhurst Road, Elk 

Grove, IL 60007. 

Date Revoked: December 18, 2005. 

Reason: Failed to maintain a valid bond. 

License Number: 016626NF. 

Name: Touchstone Shipping & 

Logistics, Inc. dba JBS Transport Line. 

Address: 17350 SH 249, Suite 320, 

Houston, TX 77064. 

Date Revoked: November 25, 2005. 

Reason: Failed to maintain a valid bond. 

Peter J. King, 

Deputy Director, Bureau of Certification and 

Licensing. 

[FR Doc. E5–8314 Filed 1–4–06; 8:45 am] 

BILLING CODE 6730–01–P 

FEDERAL RESERVE SYSTEM 

Formations of, Acquisitions by, and 

Mergers of Bank Holding Companies 

The companies listed in this notice 

have applied to the Board for approval, 

pursuant to the Bank Holding Company 

Act of 1956 (12 U.S.C. 1841 et seq.) 

(BHC Act), Regulation Y (12 CFR part 

225), and all other applicable statutes 

and regulations to become a bank 

holding company and/or to acquire the 

assets or the ownership of, control of, or 

the power to vote shares of a bank or 

bank holding company and all of the 

banks and nonbanking companies 

owned by the bank holding company, 

including the companies listed below. 

The applications listed below, as well 

as other related filings required by the 

Board, are available for immediate 

inspection at the Federal Reserve Bank 

indicated. The application also will be 

available for inspection at the offices of 

the Board of Governors. Interested 

persons may express their views in 

writing on the standards enumerated in 

the BHC Act (12 U.S.C. 1842(c)). If the 

proposal also involves the acquisition of 

a nonbanking company, the review also 

includes whether the acquisition of the 

nonbanking company complies with the 

standards in section 4 of the BHC Act 

(12 U.S.C. 1843). Unless otherwise 

noted, nonbanking activities will be 

conducted throughout the United States. 

Additional information on all bank 

holding companies may be obtained 

from the National Information Center 

Web site at http://www.ffiec.gov/nic/. 

Unless otherwise noted, comments 

regarding each of these applications 

must be received at the Reserve Bank 

indicated or the offices of the Board of 

Governors not later than January 31, 

2005. 

A. Federal Reserve Bank of Atlanta 

(Andre Anderson, Vice President) 1000 

Peachtree Street, NE., Atlanta, Georgia 

30303: 

1. Whitney Holding Corporation, New 

Orleans, Louisiana, to merge with First 

National Bancshares, Inc., and thereby 

indirectly acquire 1st National Bank and 

Trust, both of Bradenton, Florida. 

Board of Governors of the Federal Reserve 

System, December 30, 2005. 

Jennifer J. Johnson, 

Secretary of the Board. 

[FR Doc. E5–8302 Filed 1–4–06; 8:45 am] 

BILLING CODE 6210–01–S 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Agency for Healthcare Research and 

Quality 

Medicare Prescription Drug, 

Improvement, and Modernization Act 

of 2003; Section 1013: Identification of 

Priority Topics for Effective Health 

Care Research 

AGENCY: Agency for Healthcare Research 

and Quality (AHRQ), HHS. 

ACTION: Notice of invitation to submit 

research recommendations. 

SUMMARY: The U.S. Department of 

Health and Human Services invites 

suggestions from interested 

organizations and knowledgeable 

individuals regarding the highest 

priorities for research, demonstration, 

and evaluation projects to support and 

improve the Medicare, Medicaid, and 

State Children Health Insurance (SCHIP) 

programs. 

The research and other activities 

undertaken and authorized by the 

above-captioned or above referenced 

statutory provision may address: 

1. The outcomes, comparative clinical 

effectiveness, and appropriateness of 

health care items and services 

(including prescription drugs); and 

2. Strategies for improving the 

efficiency and effectiveness of such 

programs, including the ways in which 

such items and services are organized, 

managed, and delivered under such 

programs. 

The statute: 

a. Requires the establishment of a 

priority setting process for identifying 

the most important topics to address, 

b. Establishes a timetable for 

development of an initial priority list 

and completion of the research; and 

c. Requires ongoing consultation with 

relevant stakeholders. 

To review the text of section 1013 of 

the Medicare Prescription Drug, 

Improvement, and Modernization Act of 

2003, please visit Section 1013. 

Research on Outcomes of Health Care 

Items and Services (PDF 21.7 KB) or 

http://www.medicare.gov/ 

medicarereform/108s1013.htm (text). 

Current priority conditions being 

studied focus on topics particularly 

relevant to Medicare beneficiaries. The 


cchase on PROD1PC60 with NOTICES
Federal Register / Vol. 71, No. 3 / Thursday, January 5, 2006 / Notices 601 

next set of priority conditions will be 

expanded to include conditions relevant 

to the Medicaid and SCHIP programs. 

The current priority conditions are: 

• Arthritis and non-traumatic joint 

disorders. 

• Cancer. 

• Chronic obstructive pulmonary 

disease and asthma. 

• Dementia including Alzheimer’s 

disease. 

• Depression and other mood 

disorders. 

• Diabetes mellitus. 

• Ischemic heart disease. 

• Peptic ulcer disease and dyspepsia. 

• Pneumonia. 

• Stroke and hypertension. 

DATES: Research recommendations for 

the next priority conditions list must be 

received by March 1, 2006. 

ADDRESSES: Recommendations for 

consideration and possible inclusion in 

the next priority list may be submitted 

electronically to the Effective Health 

Care Program Web site, http:// 

www.EffectiveHealthCare.ahrq.gov, or emailed to 

EffectiveHealthCare@ahrq.gov. 

Recommendations may also be mailed 

to: AHRQ Effective Health Care Program 

c/o Center for Outcomes and Evidence, 

Agency for Healthcare Research and 

Quality, 540 Gaither Road, Rockville, 

MD 20850. 

All comments will be posted in an 

electronic reading room at: http:// 

www.EffectiveHealthCare.ahrq.gov. 

FOR FURTHER INFORMATION CONTACT: 

Effective Health Care Program at (301) 

427–1502 or Effective 

HealthCare@ahrq.gov. 

More information about the Effective 

Health Care Program is available at 

http:// 

www.EffectiveHealthCare.ahrq.gov. 

SUPPLEMENTARY INFORMATION: 

Recommendations for research that are 

made by the Centers for Medicare & 

Medicaid Services (CMS), the States, 

and other stakeholders will be reviewed 

and prioritized by a steering committee 

composed of representatives from the 

following components of the U.S. 

Department of Health and Human 

Services: 

• Office of the Secretary. 

• Assistant Secretary for Planning 

and Evaluation (ASPE). 

• Assistant Secretary for Budget, 

Technology, and Finance (ASBTF). 

• Centers for Medicare & Medicaid 

Services (CMS). 

• Food and Drug Administration 

(FDA). 

• Agency for Healthcare Research and 

Quality (AHRQ, the agency designated 

by the statute to carry out the research). 

If issues arise for which the expertise 

of other components of the U.S. 

Department of Health and Human 

Services or other Federal departments 

would be helpful in prioritizing 

suggested research topics, 

representatives from those entities will 

be added to, or consulted by the 

Steering Committee as warranted. 

Steering Committee staff will prepare 

a preliminary ranking of suggested 

topics for study taking into 

consideration factors suggested by the 

terms of Section 1013(a)(2)(C): Health 

care items or services that impose high 

costs on Medicare, Medicaid, or SCHIP 

programs; those which may be 

underutilized or overutilized; and those 

which may significantly improve the 

prevention, treatment, or cure of 

diseases and conditions which impose 

high direct or indirect costs on patients 

or society. 

Stakeholder Consultation 

The statute requires a broad, ongoing 

process of consultation with relevant 

stakeholders. Because two of the 

programs addressed by the statute are 

administered by the States, the 

Department will work with the States to 

develop an effective process for 

identifying their priority 

recommendations for research. 

To meet the requirement for ongoing 

consultation with other stakeholders, 

the Department will issue a specific 

solicitation for research 

recommendations every year and will 

permit stakeholders to submit research 

recommendations throughout the year. 

Dated: December 28, 2005. 

Carolyn M. Clancy, 

Director. 

[FR Doc. 06–69 Filed 1–4–06; 8:45 am] 

BILLING CODE 4160–90–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Statement of Organization, Functions, 

and Delegations of Authority 

Part C (Centers for Disease Control 

and Prevention) of the Statement of 

Organization, Functions, and 

Delegations of Authority of the 

Department of Health and Human 

Services (45 FR 67772–76, dated 

October 14, 1980, and corrected at 45 FR 

69296, October 20, 1980, as amended 

most recently at 70 FR 72842–72843, 

dated December 7, 2005) is amended to 

reflect the reorganization of the Office of 

Health and Safety, within the Office of 

the Director, Centers for Disease Control 

and Prevention. 

Section C–B, Organization and 

Functions, is hereby amended as 

follows: 

Delete in its entirety the titles and 

functional statements for the Office of 

Health and Safety (CA1). 

After the mission statement for the 

Management Information Systems 

Office (CAJN), Office of the Chief 

Operating Officer (CAJ), insert the 

following: 

Office of Health and Safety (CAJP). 

The key responsibility of the Office of 

Health and Safety (OHS) of the Centers 

for Disease Control and Prevention 

(CDC) is to protect the welfare of 

workers as they carry out their public 

health mission. By creating a safe, 

healthful workplace environment, by 

preventing work-related injury and 

illness, and by promoting safe work 

practices, the office improves worker 

morale, increases efficiency and 

contributes to the creation of sound 

public health science. OHS also serves 

as a significant resource of subject 

matter expertise for the national and 

international community in the field of 

biosafety, and works with key partners, 

such as the World Health Organization 

and others, on critical health and safety 

issues around the globe. 

More specifically, the OHS: (1) 

Provides leadership and service for the 

CDC Health and Safety Program (HSP) 

to proactively ensure safe and healthy 

workplaces at CDC worksites for CDC 

employees, contractors, and visitors 

(including deployed personnel), and to 

protect the environment and 

communities adjacent to CDC-owned 

and leased facilities; (2) promotes 

healthy and safe work practices to 

prevent injury and illness, and provides 

occupational medical, employee 

assistance, and worksite health 

promotion/lifestyle services; (3) 

provides advice and counsel to the CDC 

Director and other senior OD and 

national centers’ staff on health, safety, 

and environment-related matters, and to 

individuals and organizations nationally 

and internationally, as requested; (4) 

provides advice, counsel, and direct 

support services to supervisors and 

employees on health, safety, and 

environment-related matters; (5) assures 

compliance with applicable federal, 

state, and local health, safety, and 

environmental (HSE) laws and 

regulations; (6) provides liaison with 

both CDC safety officers and staff, and 

other partners such as Health and 

Human Services (HHS) health and 

safety officials, Occupational Safety and 

Health Administration (OSHA), 

Environmental Protection Agency 


cchase on PROD1PC60 with NOTICES